GNH USA

Europe — EMA

Minovital (Minoxidil)

GNH USA supplies Minovital (Minoxidil), a potassium channel opener for androgenetic alopecia and other hair loss conditions. Request a quote for supply.

Request sourcing

1
Pack/s

What is Minoxidil?

Minoxidil, the active ingredient in Minovital, is a potassium channel opener presented as a topical solution for topical use. It treats androgenetic alopecia and other forms of hair loss in adults.\n\nGNH India supplies Minovital as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Minoxidil used for?

Minoxidil is used to address conditions related to androgen‑dependent hair loss.\n\n- Male pattern hair loss (androgenetic alopecia): Increases hair shaft thickness and reduces shedding.\n- Female pattern hair loss: Enhances scalp hair regrowth and density.\n- General hair thinning: Supports maintenance of existing hair and stimulates new growth.

What are the side effects of Minoxidil?

Topical Minoxidil may cause local and systemic adverse reactions, most of which are mild and reversible.\n\nCommon Side Effects:\n- Scalp irritation: Redness, itching or burning at the application site.\n- Dryness or flaking: Peeling of the scalp skin.\n- Unwanted facial hair growth: Hypertrichosis in adjacent areas.\n- Temporary hair shedding: Initial increase in hair loss during early treatment.\n\nSerious or Rare Side Effects:\n- Cardiovascular effects: Rapid heartbeat, chest pain or dizziness.\n- Severe allergic reaction: Swelling, rash, or difficulty breathing.\n- Hypotension: Unusually low blood pressure after extensive absorption.\n- Contact dermatitis: Severe skin inflammation requiring medical attention.

What precautions apply to Minoxidil?

When using Minovital, several precautions should be observed to ensure safety and effectiveness.\n\n- Application area: Apply only to dry scalp and avoid eyes, nose or mouth.\n- Quantity: Use the amount prescribed; excess may increase systemic absorption.\n- Pre‑existing heart conditions: Consult a healthcare professional before use.\n- Pregnancy and breastfeeding: Use only if clearly indicated by a physician.\n- Concomitant scalp treatments: Discontinue other topical agents unless advised.\n- Store at ambient temperature: Keep below 25°C in the original container, protect from moisture and direct sunlight.

What does Minoxidil interact with?

Minoxidil can interact with certain medications and substances, affecting its safety profile.\n\nMajor Interactions (Avoid):\n- Oral antihypertensives (e.g., beta‑blockers, ACE inhibitors): May cause additive blood‑pressure lowering effects.\n- Other vasodilators (e.g., nitroglycerin): Increased risk of hypotension.\n\nModerate Interactions (Monitor Closely):\n- Oral retinoids (e.g., isotretinoin): May enhance scalp irritation.\n- Hair dyes or chemical treatments: Potential for increased local irritation.\n- Lithium therapy: Possible alteration of hair growth patterns.\n- Alcohol excess: May increase systemic absorption and cardiovascular effects.

Frequently asked questions

What is Minovital used for?+
Minovital contains minoxidil, a topical agent indicated for the treatment of androgenetic alopecia and other forms of hair loss. It is applied to the scalp to promote hair regrowth, increase hair shaft thickness, and reduce further shedding in both men and women.
How does minoxidil work?+
Minoxidil works by opening ATP‑sensitive potassium channels in the cells of hair follicles. This leads to vasodilation, improved blood flow, and enhanced delivery of oxygen and nutrients to the follicle, which prolongs the growth (anagen) phase and stimulates new hair formation.
What is the usual dose of Minovital?+
The appropriate dose of Minovital is determined by a qualified healthcare professional. Typically, a specific amount of the topical solution is applied to the affected scalp area once or twice daily, but the exact regimen should follow the prescriber’s instructions.
Is Minovital safe during pregnancy or breastfeeding?+
The safety of minoxidil in pregnancy and lactation has not been definitively established. Women who are pregnant, planning to become pregnant, or breastfeeding should only use Minovital if clearly advised by their physician after weighing potential risks and benefits.
How do I order Minovital from GNH USA?+
To order Minovital, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Minovital compare with the main alternative drug?+
The most common alternative for androgenetic alopecia is oral finasteride, which works by inhibiting the conversion of testosterone to dihydrotestosterone. Minovital, as a topical potassium channel opener, acts locally on the scalp without systemic hormonal effects, making it suitable for patients who prefer a non‑systemic option.
How should Minovital be stored and handled?+
Minovital should be stored at ambient temperature, preferably below 25 °C, in its original container. Keep the product away from moisture, direct sunlight, and extreme heat. Ensure the cap is tightly closed after each use to maintain product stability.
How is Minovital administered?+
Minovital is applied directly to the clean, dry scalp. The prescribed amount is usually measured with the supplied dropper or applicator and spread evenly over the affected area. Hands should be washed after application, and the scalp should be allowed to dry before using other hair products.
What are the most serious risks to watch for while using Minovital?+
Serious adverse reactions, although rare, include rapid heartbeat, chest pain, dizziness, severe allergic responses such as swelling or difficulty breathing, and significant drops in blood pressure. Users should seek immediate medical attention if any of these symptoms develop.
Who should not use Minovital?+
Minovital should be avoided by individuals with known hypersensitivity to minoxidil or any component of the formulation, those with severe cardiovascular disease without medical supervision, and anyone who is pregnant or breastfeeding unless a physician explicitly recommends its use.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Minoxidil
Route
Cutaneous Use
Manufacturer
Laboratorio Terapeutico M.R. S.R.L.
Origin
EU

Related products